A Phase 3 Study of SYM-1219 Treatment of Women and Post-Menarchal Adolescent Girls With Bacterial Vaginosis

Clinical trial NCT02418845 · COMPLETED

Trial details

NCT number: NCT02418845
Sponsor: Symbiomix Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bacterial Vaginosis

Start date: 2015-05-28
Primary completion: 2015-10-05
Enrollment: 189

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.